Publication date: 28 October 2023
Source: Cancer Letters, Volume 575
Author(s): Ruo-Nan Zhang, Zhi-Qian Jing, Lu Zhang, Zhi-Jun Sun
EMP3 as a key downstream target of miR-663a regulation interferes with MAPK/ERK signaling pathway to inhibit gallbladder cancer progression
Publication date: 28 October 2023
Source: Cancer Letters, Volume 575
Author(s): Qiang Ma, Yijian Zhang, Haibin Liang, Fei Zhang, Fatao Liu, Shili Chen, Yunping Hu, Lin Jiang, Yajuan Hao, Maolan Li, Yingbin Liu
Inflammatory cytokine-regulated <em>LNCPTCTS</em> suppresses thyroid cancer progression via enhancing Snail nuclear export
Publication date: 28 October 2023
Source: Cancer Letters, Volume 575
Author(s): Chi Ma, Nasha Zhang, Teng Wang, Haixia Guan, Yizhou Huang, Linying Huang, Yanxiu Zheng, Long Zhang, Linyu Han, Yanfei Huo, Yanting Yang, Haitao Zheng, Ming Yang
Cooperation between IRTKS and deubiquitinase OTUD4 enhances the SETDB1-mediated H3K9 trimethylation that promotes tumor metastasis via suppressing E-cadherin expression
Publication date: 28 October 2023
Source: Cancer Letters, Volume 575
Author(s): Xiaofang Cui, Xueying Shang, Jia Xie, Chenyi Xie, Zhanyun Tang, Qing Luo, Chongchao Wu, Guangxing Wang, Na Wang, Kunyan He, Lan Wang, Liyu Huang, Bingbing Wan, Robert G. Roeder, Ze-Guang Han
Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer
Publication date: 28 October 2023
Source: Cancer Letters, Volume 575
Author(s): Prabhakar Pitta Venkata, Sridharan Jayamohan, Yi He, Salvador Alejo, Jessica D. Johnson, Bridgitte E. Palacios, Uday P. Pratap, Yihong Chen, Zexuan Liu, Yi Zou, Zhao Lai, Takayoshi Suzuki, Suryavathi Viswanadhapalli, Susan T. Weintraub, Srinath Palakurthi, Philip T. Valente, Rajeshwar R. Tekmal, Edward R. Kost, Ratna K. Vadlamudi, Gangadhara R. Sareddy
Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy
Publication date: 28 October 2023
Source: Cancer Letters, Volume 575
Author(s): Zhangyi Luo, Katherine M. Eichinger, Anju Zhang, Song Li
Editorial: The progress and challenges of hematological malignancies in the era of big data and new therapy
Publication date: 28 October 2023
Source: Cancer Letters, Volume 575
Author(s): Hongbo Hu
FABP4 in macrophages facilitates obesity-associated pancreatic cancer progression via the NLRP3/IL-1β axis
Publication date: 28 October 2023
Source: Cancer Letters, Volume 575
Author(s): Jian Yang, Shujie Liu, Yongzheng Li, Zhiyao Fan, Yufan Meng, Bin Zhou, Guangyong Zhang, Hanxiang Zhan
Engineered mesenchymal stem cell exosomes loaded with miR-34c-5p selectively promote eradication of acute myeloid leukemia stem cells
Publication date: 28 October 2023
Source: Cancer Letters, Volume 575
Author(s): Jin Wen, Ying Chen, Chenxi Liao, Xiao Ma, Mengyuan Wang, Qian Li, Di Wang, Yingnan Li, Xiaolan Zhang, Lei Li, Hao Zhou, Jing Zou, Lingbo Liu, Danyue Peng
Understanding cervical cancer at single-cell resolution
Publication date: 1 November 2023
Source: Cancer Letters, Volume 576
Author(s): Shengqin Yue, Qian Wang, Jiajun Zhang, Qinyong Hu, Chao Liu